Friedrichs, M. (2023). A web-based annotation tool for clinical trial failure reasons. GMS Medizinische Informatik, Biometrie Und Epidemiologie, 19, Doc02. doi: 10.3205/mibe000241

Filter:

Trial ID Phase Status Type
Results Reported Result Refs Exist Enrollment From To
Free Text
Annotations

7805 Trials matched filter criteria

Status:   Withdrawn   Suspended   Terminated
Trial Updated /
Type
Status Phase Were
Results
Reported
Reported
Actual
Enrollment
(MeSH) Terms Why Stopped
Limitations And Caveats
Annotator decisions
NCT00491738
Details
2009-04-10
Interventional
216 
Bevacizumab Sunitinib
Carcinoma, Rena… Renal Cell Carc…
Based on the data collected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated.
Based on the early safety results from this study, Genentech terminated further recruitment and discontinued treatment. Insufficient efficacy information was available to perform additional outcome analyses.
NCT00369044
Details
2009-04-08
Interventional
2/3-
Prednisone
Heart Failure Heart Failure, …
-
-
NCT00315549
Details
2009-04-03
Interventional
3233 
Penicillins Telithromycin
Pharyngitis Tonsillitis
Pediatric development program terminated by sponsor
-
NCT00315042
Details
2009-04-03
Interventional
3314 
Penicillins Telithromycin
Pharyngitis Tonsillitis
Pediatric development program terminated by sponsor
-
NCT00315003
Details
2009-04-03
Interventional
3-
Azithromycin Telithromycin
Otitis Otitis Media Otitis Media, S… Suppuration Otitis Media, P…
Pediatric development program terminated by sponsor
-
NCT00174811
Details
2009-04-03
Interventional
3639 
Telithromycin
Otitis Otitis Media
Pediatric development program terminated by sponsor
-
NCT00126308
Details
2009-04-02
Interventional
4100 
Mannitol
HIV-Associated … Lipodystrophy HIV Infections HIV-Associated …
no change in primary endpoint at week 48
-
NCT00394303
Details
2009-04-01
Interventional
4-
Insulin
Coronary Artery…
Trial suspended on 26 February, following the publication of a trial with negative results (Ann Intern Med 146(4), 2007). Pending ethics committee re-approval.
-
NCT00396240
Details
2009-03-26
Interventional
4-
Rosuvastatin Ca…
Hypercholestero… Primary Hyperch…
study cancelled prior to FSI
-
NCT00524095
Details
2009-03-13
Interventional
2210 
Azithromycin Fluticasone Xhance
Bronchiectasis Bronchitis Bronchitis, Chr… Lung Diseases Chronic Bronchi… Pulmonary Disea…
we decided not to go on treatment phase
-
NCT00296257
Details
2009-03-13
Interventional
2312 
Rimacalib
Arthritis Arthritis, Rheu… Rheumatoid Arth…
-
-
NCT00665418
Details
2009-03-12
Interventional
440 
Sevoflurane
Laryngismus Laryngospasm
Recruitment finished earlier, because all 40 patients enrolled
-
NCT00535340
2006-004147-33
Details
2009-03-12
Interventional
355 
Amibegron Amibegron hydro…
Anxiety Disorde…
reprioritization of indications
-
NCT00397098
2006-002253-71
Details
2009-03-12
Interventional
3257 
Amibegron Amibegron hydro…
Anxiety Disorde… Recurrence
reprioritization of indications
-
NCT00478517
Details
2009-03-11
Interventional
1-
Epoetin Alfa
Wounds and Inju… Spinal Trauma W…
-
-
NCT00272415
Details
2009-03-11
Interventional
1-
Temozolomide
Melanoma
-
-
NCT00196677
Details
2009-03-11
Interventional
1/2-
Vitamins
Glaucomatous Ne…
The trial was terminated due to investigator's decision
-
NCT00593619
Details
2009-03-03
Interventional
4-
Dextrans Ferric Oxide, S… Iron Iron-Dextran Co…
Anemia, Iron-De… Iron Deficienci… Iron Deficiency… Perioperative B…
Interim Analysis and review by Data Safety Monitoring Board
-
NCT00847678
Details
2009-02-19
Interventional
238 
Amphotericin B Efungumab Flucytosine Liposomal ampho…
Meningitis Meningitis, Cry… Cryptococcal Me…
-
-
NCT00225355
2004-000949-38
Details
2009-02-19
Interventional
4-
Rosiglitazone
Angina Pectoris Angina, Stable Metabolic Syndr… Metabolic Syndr…
-
-